First-Line Chemotherapy with Paclitaxel and Platinum for Advanced and Recurrent Cancer of the Cervix—A Phase II Study

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

1996 • 2,766 citations

Cancer statistics, 1998

1998 • 2,407 citations

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.

1997 • 268 citations

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.

1996 • 220 citations

Paclitaxel and Cisplatin as First-Line Therapy in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

1999 • 208 citations

A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.

1989 • 146 citations

Cisplatin in advanced cancer of the cervix: an update.

1991 • 83 citations

Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.

1987 • 79 citations

Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck.

1993 • 61 citations

The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.

1995 • 61 citations

An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix

1997 • 58 citations

The role of paclitaxel in the management of patients with carcinoma of the cervix.

1997 • 15 citations